These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 18318443

  • 1. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Fransvea E, Angelotti U, Antonaci S, Giannelli G.
    Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
    [Abstract] [Full Text] [Related]

  • 2. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
    Fransvea E, Mazzocca A, Antonaci S, Giannelli G.
    Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 4. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S.
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [Abstract] [Full Text] [Related]

  • 5. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q, Liu G, Shao D, Wang J, Yuan H, Chen T, Zhai R, Ni W, Tai G.
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
    Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, Giannelli G.
    Hepatology; 2010 Feb; 51(2):523-34. PubMed ID: 19821534
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 8. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L, Tung-Ping Poon R, Yau S, Chow A, Lam C, Li HS, Chung-Cheung Yau T, Law WL, Pang R.
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L, Sancho P, Bertran E, Fabregat I.
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M.
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
    Wang Q, Yu T, Yuan Y, Zhuang H, Wang Z, Liu X, Feng M.
    J Surg Oncol; 2013 Mar 01; 107(4):422-7. PubMed ID: 22833259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
    Karmakar S, Das C.
    J Reprod Immunol; 2004 Dec 01; 64(1-2):9-29. PubMed ID: 15596224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.